30 November 2021
Opinion: How to effectively combat COVID-19
Wenn jemand von Alternativlosigkeit spricht, dann wurden mit Sicherheit nicht alle Anstrengungen unternommen, um zu einer Lösung beizutragen. In meinem persönlichen Statement sind Vorschläge zur Optimierung von Impfstoffen beschrieben.
Professor Atanas Atanasov hat mein Statement auf der von ihm betriebenen Webseite DHPSP (Digital Health And Patient Safety Platform) veröffentlicht:
https://digitalpatientsafety.com/forum/
If someone speaks of no alternative, then certainly not every effort has been made to contribute to a solution. My personal statement describes proposals for optimising vaccines.
Professor Atanas Atanasov has published my statement on the website DHPSP (Digital Health And Patient Safety Platform), which he runs:
https://digitalpatientsafety.com/forum/
Professor Atanas Atanasov is a molecular biologist, Principle Investigator of Ludwig Boltzmann Institute for Digital Health and Patient Safety (LBIDHPS) at Medical University of Vienna (Austria), Adjunct Professor at IGAB PAS (Poland), Guest-Professor at Bulgarian Academy of Sciences (Bulgaria), Guest-Lecturer at the University of Vienna (Austria), and Editor-in-Chief of Current Research in Biotechnology (CRBIOTECH, Elsevier).
DHPSP social media channels include: Twitter, LinkedIn, and Facebook.